Urogen Pharma Ltd at Piper Sandler Healthcare Conference Transcript
Welcome, everybody. My name is Kelsey Goodwin. I'm one of the analysts here at Piper Sandler. With me, I have the CEO, Liz Barrett of UroGen Pharma.
Hi.
Thanks for joining us.
Thank you. Letâs kick it off with maybe just a quick, one to two minute summary of UroGen, where we stand heading into 2026.
Oh, no, great. Look, take a step back for those that are not familiar with our company. Our company was founded on an unmet need by urologists to deliver local medicine to the urothelium. In an area where normal medicines because they're in aqueous solutions just get urinated out very quickly, so they don't really have an opportunity to work on cancer cells. So the chemists in Israel developed what we call RTGel. It's
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
